SEARCH

SEARCH BY CITATION

References

  • Allarakhia IN, Garofalo E, Komarynski MA, Robertson PL. (1996) Valproic acid and thrombocytopenia in children: a case-controlled retrospective study. Pediatr Neurol 14:303307.
  • Anderson GD, Lin Y-X, Berge C, Ojemann GA. (1997) Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J Neurosurg 87:252256.
  • Barr RD, Copeland SA, Stockwell ML, Morris N, Kelton JC. (1982) Valproic acid and immune thrombocytopenia. Arch Dis Child 57:681684.
  • Beydoun A, Sackellares JC, Shu V. (1997) Safety and efficacy of divalproate sodium monotherapy in partial epilepsy: a double-blind, concentration–response design clinical trial. Neurology 48:182188.
  • Conley EL, Coley KC, Pollock BG, Dapos SV, Maxwell R, Branch RA. (2001) Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital. Pharmacotherapy 21:13251330.
  • Coulter DL, Wu H, Allen RJ. (1980) Valproic acid therapy in childhood epilepsy. JAMA 244:785788.
  • Delgado MR, Riela AR, Mills J, Browne R, Roach ES. (1994) Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Clin Neurol 9:311314.
  • Ganick DJ, Sunder T, Finley JL. (1990) Severe hematologic toxicity of valproic acid. A report of four patients. Am J Pediatr Hematol Oncol 12:8085.
  • Gidal B, Spencer N, Maly M, Pitterle M, Williams E, Collins M, Jones J. (1994) Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration. Neurology 44:14181422.
  • Hauser E, Seidl R, Freilinger M, Male C, Herkner K. (1996) Hematologic manifestations and impaired liver synthesis function during valproate monotherapy. Brain Dev 18:105109.
  • Hoffman LM. (1982) Sodium valproate and thrombocytopenia. Can Med Assoc J 126:358359.
  • Kishi T, Fujita N, Kawaguchi H, Ishimae M, Watanabe K, Tanaka T. (1994) Bone marrow suppression induced by high dose valproic acid. Arch Dis Child 71:153155.
  • Levy RH. (1984) Variability in level-dose ratio of valproate: monotherapy versus polytherapy. Epilepsia 25:S10S13.
  • Loiseau P, Brachet A, Henry P. (1975) Concentration of dipropylacetate in plasma. Epilepsia 16:609615.
  • Loiseau P. (1981) Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 22:141146.
  • May RB, Sunder TR. (1993) Hematological manifestations of long-term valproate therapy. Epilepsia 34:10981101.
  • Morris N, Barr RD, Pai KR, Kelton JG. (1981) Valproic acid and thrombocytopenia. Can Med Assoc J 125:6364.
  • Neophytides AN, Nutt JG, Lodish JR. (1979) Thrombocytopenia associated with sodium valproate treatment. Ann Neurol 5:389390.
  • Oluboka OJ, Haslam D, Gardner DM. (2000) Pancytopenia and valproic acid: a dose-related association. J Am Geriatr Soc 48:349350.
  • Raworth RE, Birchall G. (1978) Sodium valproate and platelet count. Lancet 1:670671.
  • Richardson SG, Fletcher DJ, Jeavons PM, Stuart J. (1976) Sodium valproate and platelet function. Br Med J 1:221222.
  • Robinson D, Langer A, Casso D, Fenn H, Yesavage J. (1995) Pancytopenia and valproic acid–a possible association. J Am Geriatr Soc 43:198.
  • Sandler RM, Emberson C, Roberts GE, Voak D, Darnborough J, Heeley AF. (1978) IgM platelet autoantibody due to sodium valproate. Br Med J 2:16831844.
  • Schobben F, Van Der Kleijn E. (1974) Determination of sodium di-n-propylacetate in plasma by gas-liquid chromatography. Pharmacol Week 109:3033.
  • Tohen M, Castillo J, Baldessarini RJ, Zarate C, Jr, Kando JC. (1995) Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry 152:413418.
  • Trannel TJ, Ahmed I, Doebert D. (2001) Occurrence of thrombocytopenia in psychiatric patients taking valproate. Am J Psychiatry 158:128130.
  • Turnbull DM, Rawlins MD, Weightman D, Chadwick DW. (1983) Plasma concentrations of sodium valproate: their clinical value. Ann Neurol 14:3842.
  • Vajda F, Morris P, Drummer O, Bladin P. (1976) Clinical and pharmacological aspects of sodium valproate. In LeggNJ (Ed). Treatment of epilepsy. MCS Consultants, Tunbridge Wells , Kent , United Kingdom , pp. 91100.
  • Verrotti A, Greco R, Matera V, Altobelli E, Morgese G, Chiarelli F. (1999) Platelet count and function in children receiving sodium valproate. Pediatr Neurol 21:611614.
  • Von Voss H, Petrich C, Karch D, Schultz H-U, Gobel U. (1976) Sodium valproate and platelet function. BMJ 2:179180.
  • Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. (2006) Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 108:29372941.
  • Winfield DA, Benton P, Espri MLE. (1976) Sodium valproate and thrombocytopenia. BMJ 2:981.
  • Wulff K, Flachs H, Wurtz-Jorgensen A, Gram L. (1977) Clinical pharmacological aspects of valproate sodium. Epilepsia 18:149157.
  • Wyngaarden JB, Smith LH, Jr, Bennett JC. (1992) Cecil textbook of medicine. 19th ed. WB Saunders, Philadelphia .